We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About PreciseDx Stock

Invest in or calculate the value of your shares in PreciseDx or other pre-IPO companies through EquityZen's platform.

Get Started

PreciseDx Stock (PRCD)

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.

About PreciseDx Stock

Founded

2019

Headquarters

New York, NY, US

Industries

Software, Artificial Intelligence, Data and Analytics

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes. Clinical teams can rely on PreciseDx for unmatched insights and actionable intelligence in determining the best treatment for each patient. Combining the power of artificial intelligence with its proprietary Morphology Feature Array™, PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making.

PreciseDx Management

Leadership team at PreciseDx

Co-Founder and Chief Medical Officer

Michael J. Donovan

Co-Founder and Chairman of the Advisory Board

Carlos Cordon

Locked Features

Join now and verify your accreditation status to gain access to:

  • PreciseDx current valuation
  • PreciseDx stock price
  • Available deals in PreciseDx and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in PreciseDx stock?

Accredited investors can buy pre-IPO stock in companies like PreciseDx through EquityZen funds. These investments are made available by existing PreciseDx shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell PreciseDx stock?

Shareholders can sell their PreciseDx stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."